Like the GLP-1 receptor, it is a cAMP-coupled GPCR present on pancreatic islet cells, but it is also notably expressed in adipose tissue and bone
Medications like Ozempic, Wegovy, Mounjaro, or Zepbound are synthetic versions of GLP-1 or similar hormones
Follow institutional peptide handling protocols for documentation and research compliance
e1 Luo J, Ko B, Elliott M, Zhou M, Lindhout DA, Phung V, et al
Mounjaro has shown higher average weight loss in trials, with up to 22.5% over 72 weeks, compared with around 15.1% for high-dose oral semaglutide over 68 weeks
On the other hand, Zepbound is intended for weight management in individuals with obesity or those overweight with conditions like high blood pressure or type 2 diabetes